pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Rising Hospital and Drug Prices Drive Up Insurance Premiums for Workers and Employers

Oct 5, 2026·read at STAT ↗Negative

Bob Herman’s investigation, based on interviews with more than twenty health policy experts and industry leaders, finds that soaring hospital and pharmaceutical prices are the primary force behind rising health insurance premiums for both employees and businesses.

Insurers set premiums largely according to the cost of care, and the study shows that the dominant factor is not how often people visit doctors or hospitals, but the high, often opaque prices charged throughout the health‑care system.

The result is a growing financial burden on workers and employers alike, who have little leverage to curb these costs, underscoring a systemic pricing problem in American health care.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Hospital and pharmaceutical prices are smothering America’s businesses”

read at STAT ↗
3,042 words · retrieved 56m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
RISING3JOURNEYLILLYPATH
drugs
infliximab3IXIFIOXYGENinfliximab biosimilar
topics
ImmunologyObesityOncologyRare Disease

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 2d agoFoghorn cuts 40% of workforceBioSpace
  • Jul 20Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independenceBioSpace
  • May 8Lilly, Gilead lead pharma’s M&A boomBioPharma Dive
  • Dec 23Fierce Biotech Layoff Tracker 2026: Foghorn cuts workforce by 40%; BioMarin drops 117 rolesFierce Biotech